Stamos Capital Partners L.P. purchased a new stake in shares of The Carlyle Group Inc. (NASDAQ:CG – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 11,980 shares of the financial services provider’s stock, valued at approximately $487,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of CG. CVA Family Office LLC purchased a new stake in The Carlyle Group during the fourth quarter valued at about $35,000. GAMMA Investing LLC purchased a new stake in shares of The Carlyle Group during the fourth quarter valued at approximately $38,000. Clear Street Markets LLC purchased a new stake in The Carlyle Group in the third quarter worth $50,000. Gold Investment Management Ltd. purchased a new stake in The Carlyle Group in the fourth quarter worth $56,000. Finally, Ramirez Asset Management Inc. purchased a new stake in The Carlyle Group in the third quarter worth $84,000. Institutional investors own 55.88% of the company’s stock.
The Carlyle Group Stock Performance
The Carlyle Group stock traded down $0.65 during midday trading on Friday, hitting $40.68. 2,844,096 shares of the company were exchanged, compared to its average volume of 1,823,280. The firm has a market capitalization of $14.64 billion, a PE ratio of -22.73, a price-to-earnings-growth ratio of 1.16 and a beta of 1.77. The Carlyle Group Inc. has a fifty-two week low of $27.13 and a fifty-two week high of $48.52. The business has a fifty day simple moving average of $44.10 and a two-hundred day simple moving average of $42.37. The company has a debt-to-equity ratio of 1.53, a quick ratio of 2.53 and a current ratio of 2.53.
The Carlyle Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 21st. Shareholders of record on Tuesday, May 14th were paid a dividend of $0.35 per share. The ex-dividend date was Monday, May 13th. This represents a $1.40 annualized dividend and a yield of 3.44%. The Carlyle Group’s dividend payout ratio (DPR) is -78.21%.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. TD Cowen reduced their price target on The Carlyle Group from $49.00 to $45.00 and set a “hold” rating for the company in a report on Thursday, May 2nd. Barclays reduced their price objective on The Carlyle Group from $56.00 to $47.00 and set an “overweight” rating for the company in a report on Thursday, May 2nd. Jefferies Financial Group reduced their price objective on The Carlyle Group from $49.00 to $44.00 and set a “hold” rating for the company in a report on Thursday, May 9th. UBS Group lifted their price objective on The Carlyle Group from $46.00 to $50.00 and gave the stock a “neutral” rating in a report on Friday, April 12th. Finally, Oppenheimer cut their price target on The Carlyle Group from $74.00 to $68.00 and set an “outperform” rating for the company in a research note on Thursday, May 2nd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $45.60.
Read Our Latest Research Report on The Carlyle Group
The Carlyle Group Profile
The Carlyle Group Inc is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES.
Further Reading
- Five stocks we like better than The Carlyle Group
- What is the FTSE 100 index?
- MarketBeat Week in Review – 6/3 – 6/7
- Consumer Discretionary Stocks Explained
- Geron Corporation: FDA Approval Fuels Stock Price Surge
- How to Invest in Biotech Stocks
- Intel’s Secret Plan for a Double-Digit Stock Rally Revealed
Want to see what other hedge funds are holding CG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Carlyle Group Inc. (NASDAQ:CG – Free Report).
Receive News & Ratings for The Carlyle Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Carlyle Group and related companies with MarketBeat.com's FREE daily email newsletter.